Article
Predictors of patient and graft survival following liver transplantation for hepatitis C.
Hepatology (Baltimore, Md.) - 1 Sept 1998
Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, Hoofnagle J
Abstract excerpt
End-stage liver disease secondary to hepatitis C virus (HCV) infection is the leading indication for liver transplantation in the United States. Recurrence of HCV infection is nearly universal. We studied the patients enrolled in the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database to determine whether pretransplantation patient or donor variables could identify a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.